Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
SINOPEC CORP
00386
| (FY)Dec 31, 2025 | (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -8.61%1.51B | -8.92%759.57M | 7.45%1.65B | 17.33%834M | 6.25%1.53B | --710.82M | 11.86%1.44B | -6.23%1.29B | 5.82%1.38B | --1.3B |
| Operating income | -8.61%1.51B | -8.92%759.57M | 7.45%1.65B | 17.33%834M | 6.25%1.53B | 710.82M | 11.86%1.44B | -6.23%1.29B | 5.82%1.38B | 1.3B |
| Cost of sales | 10.63%-1.06B | 13.36%-520.01M | -4.31%-1.19B | -16.27%-600.21M | 0.61%-1.14B | ---516.21M | -17.39%-1.15B | 9.95%-976.97M | -7.30%-1.08B | ---1.01B |
| Operating expenses | 10.63%-1.06B | 13.36%-520.01M | -4.31%-1.19B | -16.27%-600.21M | 0.61%-1.14B | -516.21M | -17.39%-1.15B | 9.95%-976.97M | -7.30%-1.08B | -1.01B |
| Gross profit | -3.39%443.69M | 2.47%239.57M | 16.51%459.25M | 20.14%233.79M | 32.77%394.17M | 194.6M | -5.35%296.88M | 7.64%313.67M | 0.65%291.39M | 289.52M |
| Administrative expenses | -1.47%-169.81M | -3.13%-72.43M | 4.46%-167.35M | -0.24%-70.23M | -25.48%-175.16M | ---70.06M | 1.22%-139.59M | -13.09%-141.31M | -3.29%-124.95M | ---120.97M |
| Impairment and provision | 137.96%9.46M | -82.27%3.44M | -308.13%-24.93M | -8.18%19.41M | -48.18%11.98M | --21.14M | 2,223.42%23.12M | 107.34%995K | -2,063.48%-13.55M | --690K |
| -Other impairment is provision | 137.96%9.46M | -82.27%3.44M | -308.13%-24.93M | -8.18%19.41M | -48.18%11.98M | --21.14M | 2,223.42%23.12M | 107.34%995K | -2,063.48%-13.55M | --690K |
| Special items of operating profit | -32.35%20.8M | -15.55%13.68M | -54.74%30.74M | 4.91%16.2M | 35.48%67.93M | --15.44M | -31.84%50.14M | 52.54%73.57M | -25.74%48.23M | --64.94M |
| Operating profit | 2.16%304.15M | -7.49%184.26M | -0.40%297.71M | 23.62%199.18M | 29.65%298.92M | 161.12M | -6.63%230.55M | 22.77%246.92M | -14.12%201.12M | 234.18M |
| Financing income | -15.96%15.57M | -25.76%7.48M | 1.60%18.52M | 4.04%10.08M | -30.72%18.23M | --9.69M | -10.36%26.31M | 11.22%29.35M | 1.19%26.39M | --26.08M |
| Financing cost | 9.06%-39.78M | 20.72%-18.43M | 13.16%-43.74M | 8.14%-23.25M | 40.08%-50.37M | ---25.31M | -3.14%-84.07M | 12.24%-81.5M | -13.53%-92.87M | ---81.8M |
| Share of profits of associates | 6.60%17.16M | -43.09%2.61M | 4.72%16.1M | 56.01%4.58M | 13.56%15.37M | --2.94M | 13.19%13.54M | 28.85%11.96M | 175.84%9.28M | --3.37M |
| Earning before tax | 2.95%297.09M | -7.70%175.92M | 2.28%288.59M | 28.40%190.58M | 51.42%282.15M | 148.43M | -9.87%186.34M | 43.64%206.73M | -20.84%143.93M | 181.83M |
| Tax | -9.89%-56.23M | 24.15%-27.25M | 7.49%-51.17M | -2.37%-35.93M | -20.35%-55.32M | ---35.1M | -28.85%-45.96M | 21.79%-35.67M | -0.99%-45.61M | ---45.17M |
| After-tax profit from continuing operations | 1.45%240.86M | -3.87%148.66M | 4.67%237.42M | 36.45%154.65M | 61.59%226.83M | 113.34M | -17.94%140.38M | 73.99%171.06M | -28.06%98.32M | 136.66M |
| Earning after tax | 1.45%240.86M | -3.87%148.66M | 4.67%237.42M | 36.45%154.65M | 61.59%226.83M | 113.34M | -17.94%140.38M | 73.99%171.06M | -28.06%98.32M | 136.66M |
| Minority profit | -3.58%70.65M | -12.85%36.92M | -5.89%73.27M | 24.37%42.37M | 77.17%77.85M | --34.07M | -27.20%43.94M | 91.72%60.36M | -21.35%31.49M | --40.03M |
| Special items of profit attributable to shareholders | ---- | --2K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Adjustment items of profit attributable to shareholders | ---- | ---1K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Profit attributable to shareholders | 3.69%170.21M | -0.49%111.74M | 10.19%164.15M | 41.65%112.29M | 54.49%148.98M | 79.27M | -12.89%96.43M | 65.64%110.7M | -30.84%66.83M | 96.63M |
| Basic earnings per share | 3.70%0.56 | 0.00%0.37 | -5.26%0.54 | 5.71%0.37 | 32.56%0.57 | 0.35 | -12.24%0.43 | 63.33%0.49 | -30.23%0.3 | 0.43 |
| Diluted earnings per share | 3.70%0.56 | 0.00%0.37 | -5.26%0.54 | 5.71%0.37 | 32.56%0.57 | 0.35 | -12.24%0.43 | 63.33%0.49 | -30.23%0.3 | 0.43 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion |
| Auditor | National Health Accounting Firm Co., Ltd. | -- | PwC | -- | PwC | -- | PwC | PwC | PwC | PwC |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.